Published April 2011 | Version v1
Journal article

Questioning the value of 99mTc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer

  • 1. Division of Diagnostic Oncology, Netherland Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066CX Amsterdam (Netherlands)
  • 2. Division of Radiotherapy, Netherland Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066CX Amsterdam (Netherlands)
  • 3. Division of Molecular Biology, Netherland Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Plesmanlaan 121, 1066CX Amsterdam (Netherlands)

Description

Annexin V imaging is suggested to provide a good indication of cancer treatment efficacy. To study the accuracy of 99mTc-AnxV imaging, we monitored chemo-sensitive and chemo-resistant tumors in a mouse breast cancer model after treatment with docetaxel. Sensitive tumors showed a slight peak in 99mTc-AnxV uptake one day post-treatment, while uptake in resistant tumors remained constant. In contrast to immunohistochemical analysis, 99mTc-AnxV imaging could not be used to predict tumor response, due to large variation between animals.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.apradiso.2010.12.012

Additional details

Identifiers

DOI
10.1016/j.apradiso.2010.12.012;
PII
S0969-8043(10)00489-6;

Publishing Information

Journal Title
Applied Radiation and Isotopes
Journal Volume
69
Journal Issue
4
Journal Page Range
p. 656-662
ISSN
0969-8043
CODEN
ARISEF

Optional Information

Copyright
Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.